**4. Conclusion**

Heart disease, aortic stenosis, atrial fibrillation, stroke, and even thromboembolic illness can all occur in patients with lifestyle diseases. Evidence now suggests that the risk of ischemic stroke in people with metabolic syndrome is significantly higher than previously anticipated. Other issues linked to metabolic syndrome include a higher chance of cancers in the colon, kidney, and gallbladder. In addition, metabolic syndrome may increase the risk of cognitive dysfunction. Finally, patients with metabolic syndrome are more likely to fall into the polypharmacy category, which means they will have higher medical expenses, be more likely to be impoverished, and have difficulty accessing high-quality treatment. Crude drugs are safe and can be expected to have the effects of improving metabolic syndrome. Treatment with complementary and alternative medicine will become effective methods. In this case, to prevent the drugs' induced secondary complications and economic problems, patients believe in alternative therapies such as plant medicinal products since they are safe, reliable, free from toxicity, and cost-effective.
